EUCTR2011-003283-78-IT进行中（未招募）不适用
A PROOF-OF-CONCEPT CLINICAL STUDY, TO ASSESS THE EFFECT OF GED-0507-34-Levo 80 mg Tablets IN INDUCTION OF REMISSION OF ACTIVE ULCERATIVE COLITIS
GIULIANI0 个研究点开始时间: 2012年3月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Written informed consent, personally signed and dated by the patient prior any study-related procedures is carried out, ie before inclusion.
- •Patients must have a relapsing ulcerative colitis for < 6 weeks (score of 4 – 10 inclusive on the UC-DAI, with a sigmoidoscopy score of 2).
- •Patients who have relapsed on maintenance therapy with 5-ASA doses of =2.4 gr/day for at least 3 months
- •Out-patients of both sexes aging 18 and over years old.
- •CMV Negative Test (at screening)
- •Female patients not of childbearing potential (post menopausal – defined as one year post menopause – surgically or biologically sterile); female patients of childbearing potential upon negative urine pregnancy test at screening and using effective method of birth control during the studyand at least for 30 days after the administration of the study drug.
- •Male patients who agree to use a condom throughout the duration of the study and for 30 days after the administration of the study drug.
- •Ability, willingness and likeliness to understand and comply with study procedures and restrictions.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 31
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 5
排除标准
- •Pregnant or breast-feeding women.
- •Patients with relapsing ulcerative colitis who have been in relapse for > 6 weeks.
- •Patients who have relapsed on maintenance therapy with doses of 5-ASA < 2.4 g/day.
- •Patients with proctitis (extent of inflammation = 15 cm), previous colonic surgery, Crohn’s disease, immediate risk of toxic megacolon or a stool culture positive for enteric pathogen.
- •The use of systemic or rectal steroids or rectal 5-ASA within the last 4 weeks
- •The use of immunosuppressants within the last 6 weeks
- •Antibiotic use within 7 days prior to the Baseline Visit will exclude patients.
- •Use prescription or non-prescription drugs, vitamins, or dietary supplements and herbal OTC products within 7 days prior to the administration of study drug
- •CMV Positive Test at screening
- •Patients having a disease or condition or any finding in his medical history, physical examination or clinical laboratory tests giving reasonable suspicion of a disease, which in the opinion of the investigator, may put the patients at risk because of participation in the study or may influence either the results of the study or the patient’s ability to participate in the study,
- •Patients with a history of drug or alcohol abuse.
- •Patients with a history of hypersensitivity to at least one ingredient of the test product.
- •Patients not able to understand information and give informed consent, or potentially presenting poor reliability (e.g. bad mental conditions).
- •Patients who used another investigational agent or who took part in a clinical trial within the last 6 months prior first dose.
研究者
相似试验
进行中（未招募）
1 期
Alginate encapsulated Stem Cell Transplantation study for Corneal diseases.CTRI/2021/07/035034Hyderabad Eye Research Foundation
进行中（未招募）
1 期
Clinical evaluation of Limbal Stromal Stem Cell for its safety and efficacy for treatment of corneal injuriesCTRI/2020/07/026891Hyderabad Eye Research Foundation
已完成
1 期
Study to assess safety and efficacy of synthetic membrane used in limbal epithelial cell transplant instead of donor membrane in blindness caused by chemical burnsCTRI/2015/08/006147Wellcome Trust for Affordable Healthcare India R D5
已完成
4 期
A proof of concept clinical investigation to evaluate the activity of Hedrin® 4% lotion in the treatment of head lice using a 1-hour application timeHead louse infestationInfections and InfestationsPediculosis and phthiriasisISRCTN95412572Thornton & Ross Ltd (UK)40
已完成
不适用
A proof of concept clinical investigation to evaluate the activity of Hedrin® 4% gel in the treatment of head lice using a 1-hour application timeISRCTN50373146Thornton & Ross Ltd (UK)40